BeOne Medicines AG Revenue

BeOne Medicines AG had revenue of 10.05B CNY in the quarter ending September 30, 2025, with 43.11% growth. This brings the company's revenue in the last twelve months to 35.40B, up 52.67% year-over-year. In the year 2024, BeOne Medicines AG had annual revenue of 27.81B with 59.51% growth.

Revenue (ttm)

35.40B CNY

Revenue Growth

+52.67%

P/S Ratio

7.25

Revenue / Employee

3.22M CNY

Employees

11,000

Market Cap

30.71B EUR

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	27.81B	10.38B	59.51%
Dec 31, 2023	17.43B	7.67B	78.53%
Dec 31, 2022	9.77B	2.29B	30.69%
Dec 31, 2021	7.47B	5.46B	270.56%
Dec 31, 2020	2.02B	-965.08M	-32.37%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
SAP SE	36.49B
Siemens Aktiengesellschaft	78.91B
Allianz SE	105.02B
Deutsche Telekom AG	121.02B
Siemens Energy AG	39.08B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	62.10B
Rheinmetall AG	11.00B
Deutsche Bank Aktiengesellschaft	29.86B

Revenue Rankings

BeOne Medicines AG News

4 weeks ago - BeiGene Non-GAAP EPADS of $2.65, revenue of $1.4B beats by $40M - Seeking Alpha
4 weeks ago - BeiGene Q3 2025 Earnings Preview - Seeking Alpha
7 months ago - U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene - Business Wire
8 months ago - BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer - Business Wire

More News